#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	488	CRP	633	633	99.53	CRP.l6.c4.ctg.1	1236	21.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	370	372	ACG	31;28;26	A;C;G	31;28;26	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	2052	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1558	65.5	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1322	1324	AGC	41;41;41	A,G;G;C	29,12;40;40	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	2052	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1558	65.5	0	HET	.	.	.	T45C	.	45	45	T	187	187	T	33	T,C	20,13	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	2052	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1558	65.5	0	HET	.	.	.	T135C	.	135	135	T	277	277	T	65	T,C	39,21	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	2052	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1558	65.5	0	HET	.	.	.	C210T	.	210	210	C	352	352	C	63	C,T	34,29	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	582	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1854	16.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1609	1611	AAA	9;9;9	A;A;A	9;9;9	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	836	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1700	26.3	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1253	1255	GAA	31;30;30	G;A;A	31;30;30	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	140	H_NS	414	414	99.03	H_NS.l6.c30.ctg.1	674	10.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	108	G	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	112	T	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	144	G	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	137	C	136	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	135	C	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	128	T	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	121	C	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	90	C	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	90	A,C	88,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	93	A	93	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	94	A	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	92	T	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	94	C	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	89	C	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	91	A	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	95	G	95	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	98	C	95	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	109	T	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	124	G	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	134	G	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	134	T	133	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	139	T	137	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	132	G	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	116	C	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	105	A	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	59	C	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	56	C	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	10	A	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	10	A	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	12	G	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	22	C	21	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	52	T	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	59	G	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	35	T	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	136	C	136	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	2560	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	112.4	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	98	C,T	56,18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	258	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1440	9.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	184	186	CGT	7;8;8	C;G;T	7;8;8	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	258	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1440	9.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1027	1029	GGC	13;13;14	G;G;C	13;13;14	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	298	PmrC	1644	1644	99.17	PmrC.l15.c30.ctg.1	1785	8.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	350	352	CTA	7;7;8	C;T;A	7;7;8	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	298	PmrC	1644	1644	99.17	PmrC.l15.c30.ctg.1	1785	8.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	869	871	CAA	10;12;13	C;A;A	10;12;13	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	298	PmrC	1644	1644	99.17	PmrC.l15.c30.ctg.1	1785	8.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	968	970	GGT	11;11;11	G;G;T	11;11;11	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	298	PmrC	1644	1644	99.17	PmrC.l15.c30.ctg.1	1785	8.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1538	1540	GTT	6;6;5	G;T;T	5;6;5	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	384	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1592	13.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	609	611	GAA	9;9;8	G;A;A	9;9;8	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	384	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1592	13.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	789	791	ACC	7;7;7	A;C;C	7;7;7	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	384	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1592	13.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	909	911	ACT	10;11;11	A;C;T	10;11;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	384	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1592	13.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1299	1301	ATC	9;11;11	A;T;C	9;11;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	538	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1312	21.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	16	18	TEM_1+	858	139	100.0	TEM_1+.l6.c30.ctg.1	139	1.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.;TEM-124
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1514	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3514	23.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	456	458	ATC	25;26;28	A;T;C	25;26;28	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1514	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3514	23.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2169	2171	AAG	16;17;17	A;A;G	16;17;17	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	702	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1583	23.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	287	289	GTC	8;8;8	G;T;C	8;8;8	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	702	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1583	23.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1028	1030	TGC	36;36;37	T;G;C	36;36;37	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1800	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3521	27.0	0	.	p	.	0	S46trunc	TRUNC	136	136	T	356	356	T	15	T	15	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1800	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3521	27.0	0	.	p	.	0	G148D	NONSYN	442	444	GGC	662	664	GAC	28;29;30	G;A;C	28;29;30	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1800	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3521	27.0	0	.	p	.	0	F240L	NONSYN	718	720	TTT	938	940	TTA	21;20;19	T,G;T;A	20,1;20;19	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1800	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3521	27.0	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2015	2017	AAT	44;44;43	A;A;T	44;43;43	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1800	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3521	27.0	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2129	2131	AGT	24;24;23	A;G;T	24;24;23	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1800	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3521	27.0	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2528	2530	GTG	27;27;27	G;T;G	27;26;27	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1800	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3521	27.0	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3083	3085	AAG	37;38;38	A;A;G	37;38;38	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	358	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1115	17.2	1	SNP	p	R45C	0	.	.	133	135	CGC	383	385	CGC	31;30;30	C;G;C	31;30;30	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	352	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1109	17.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	214	216	TTC	22;22;22	T;T;C	22;22;22	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	352	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1109	17.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	478	480	GGG	24;24;26	G;G;G	24;24;26	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	531	114	adiY	762	740	99.59	adiY.l6.c4.ctg.1	866	6.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	384	386	CTT	9;9;9	C;T;T	9;9;9	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1574	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3134	27.0	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2077	2079	GCA	29;30;30	G;C;A	28;30;30	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1574	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3134	27.0	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2338	2340	ACC	26;27;28	A;C;C	25;26;28	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1574	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3134	27.0	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2647	2649	GCC	22;23;24	G;C;C	22;23;24	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	798	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2371	18.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	212	214	GCT	5;6;6	G;C;T	5;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	798	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2371	18.0	0	.	p	.	0	D77E	NONSYN	229	231	GAT	332	334	GAG	6;6;6	G;A;G	6;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	798	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2371	18.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	368	370	TGC	11;11;12	T;G;C	11;11;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	798	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2371	18.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	551	553	GTT	23;23;23	G;T;T	23;23;23	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	798	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2371	18.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	701	703	CAC	18;19;18	C;A;C	18;19;18	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	798	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2371	18.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	986	988	ATG	32;32;32	A;T;G	31;32;32	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	798	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2371	18.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1982	1984	CGC	15;12;12	C;G;C	15;12;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	322	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1187	14.3	0	.	p	.	0	S221T	NONSYN	661	663	AGC	832	834	ACC	5;5;4	A;C;C	5;5;4	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	322	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1187	14.3	0	.	p	.	0	P225S	NONSYN	673	675	CCG	844	846	TCG	3;3;3	T;C;G	3;3;3	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	539	312	baeR	723	723	97.65	baeR.l6.c4.ctg.1	1139	14.7	0	.	p	.	0	S214F	NONSYN	640	642	TCT	859	861	TTT	11;11;11	T;T,G;T	11;10,1;11	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	588	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1576	18.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1286	1288	AAA	6;6;6	A;A;A	6;6;6	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	588	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1576	18.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1298	1300	GAG	7;5;5	G;A;G	6;4;4	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	588	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1576	18.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1304	1306	CAC	5;5;5	C;A;C	5;4;4	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	588	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1576	18.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1358	1360	GAG	9;10;11	G;A;G	9;10;11	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	539	786	cpxA	1374	1374	98.76	cpxA.l15.c4.ctg.1	1829	23.0	0	.	p	.	0	A231T	NONSYN	691	693	GCG	945	947	ACG	28;33;32	A;C;G	28;33;32	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	544	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1190	24.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	382	cysB	975	975	99.28	cysB.l6.c4.ctg.1	1355	15.0	0	.	p	.	0	T132I	NONSYN	394	396	ACA	627	629	ATA	14;15;15	A;T;A	14;15;15	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	590	emrA	1173	1173	98.38	emrA.l6.c4.ctg.1	1701	18.6	0	.	p	.	0	I219V	NONSYN	655	657	ATC	938	940	GTC	28;27;27	G;T;C	26;26;27	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	894	emrB	1539	1539	99.81	emrB.l15.c30.ctg.1	2062	23.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	662	emrD	1191	1191	98.57	emrD.l15.c30.ctg.1	1394	24.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	813	815	AGC	30;30;28	A;G;C	30;30;28	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	0	20	emrE_1	333	93	96.77	emrE_1.l6.c4.ctg.1	112	3.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	0	20	emrE_1	333	134	92.54	emrE_1.l6.c4.ctg.2	134	2.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	450	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1308	18.0	0	.	p	.	0	K176R	NONSYN	526	528	AAG	581	583	AGG	22;22;22	A;G;G	22;22;22	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	450	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1308	18.0	0	.	p	.	0	N306D	NONSYN	916	918	AAC	971	973	GAC	14;15;15	G;A;C	14;15;15	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	346	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1018	18.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	600	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	1987	16.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	246	evgA	615	615	99.19	evgA.l15.c17.ctg.1	1101	12.0	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	403	405	CTG	13;13;13	C;T;G	13;13;13	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	179	181	AAA	7;7;7	A;A;A	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	914	916	CAT	17;17;18	C;A;T	17;17;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	968	970	CAT	11;12;11	C;A;T	11;12;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	986	988	AGA	16;16;16	A;G;A	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1001	1003	AAT	16;16;16	A;A;T	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1148	1150	TCC	10;9;9	T;C;C	10;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1313	1315	ATT	14;13;13	A;T;T	14;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1334	1336	GAT	12;12;12	G;A;T	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1448	1450	GTT	22;21;20	G;T;T	22;21;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	2476	97.9	evgS.l15.c30.ctg.1	2641	21.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1733	1735	CAC	22;21;21	C;A;C	22;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	506	96.64	evgS.l15.c30.ctg.2	513	10.9	0	.	p	.	0	I251V	NONSYN	751	753	ATT	143	145	GTT	10;9;9	G;T;T	10;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	506	96.64	evgS.l15.c30.ctg.2	513	10.9	0	.	p	.	0	N303D	NONSYN	907	909	AAT	299	301	GAT	16;13;11	G;A;T	16;13;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	506	96.64	evgS.l15.c30.ctg.2	513	10.9	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	467	469	AAT	8;8;8	A;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	506	96.64	evgS.l15.c30.ctg.2	513	10.9	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	488	490	TTA	4;4;4	T;T;A	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	620	96.94	evgS.l15.c30.ctg.3	749	12.2	0	.	p	.	0	T38I	NONSYN	112	114	ACA	241	243	ATA	6;6;6	A;T;A	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	620	96.94	evgS.l15.c30.ctg.3	749	12.2	0	.	p	.	0	L42V	NONSYN	124	126	CTA	253	255	GTA	6;6;7	G;T;A	6;6;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	620	96.94	evgS.l15.c30.ctg.3	749	12.2	0	.	p	.	0	A93T	NONSYN	277	279	GCG	406	408	ACG	13;13;13	A;C;G	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	620	96.94	evgS.l15.c30.ctg.3	749	12.2	0	.	p	.	0	A114E	NONSYN	340	342	GCA	469	471	GAA	11;10;11	G;A;A	10;10;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	620	96.94	evgS.l15.c30.ctg.3	749	12.2	0	.	p	.	0	T127A	NONSYN	379	381	ACT	508	510	GCT	16;16;16	G;C;T	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	620	96.94	evgS.l15.c30.ctg.3	749	12.2	0	.	p	.	0	N133D	NONSYN	397	399	AAT	526	528	GAT	12;12;12	G;A;T	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	620	96.94	evgS.l15.c30.ctg.3	749	12.2	0	.	p	.	0	P162S	NONSYN	484	486	CCA	613	615	TCA	5;5;5	T;C;A	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1328	evgS	3594	620	96.94	evgS.l15.c30.ctg.3	749	12.2	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	742	744	CAG	3;2;2	C;A;G	3;2;2	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	480	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1325	19.4	1	SNP	p	P64A	0	.	.	190	192	CCA	370	372	CCA	37;36;37	C;C;A	37;36;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	480	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1325	19.4	1	SNP	p	P64H	0	.	.	190	192	CCA	370	372	CCA	37;36;37	C;C;A	37;36;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	480	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1325	19.4	1	SNP	p	P64R	0	.	.	190	192	CCA	370	372	CCA	37;36;37	C;C;A	37;36;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	480	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1325	19.4	1	SNP	p	P64L	0	.	.	190	192	CCA	370	372	CCA	37;36;37	C;C;A	37;36;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	480	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1325	19.4	1	SNP	p	P64S	0	.	.	190	192	CCA	370	372	CCA	37;36;37	C;C;A	37;36;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	256	gadE	528	528	100.0	gadE.l15.c4.ctg.1	935	14.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	86	gadW	729	178	93.26	gadW.l15.c30.ctg.1	178	5.8	0	.	p	.	0	D100E	NONSYN	298	300	GAC	17	19	GAA	5;5;6	G;A;A	5;5;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	86	gadW	729	178	93.26	gadW.l15.c30.ctg.1	178	5.8	0	.	p	.	0	P101S	NONSYN	301	303	CCC	20	22	TCC	6;7;7	T;C;C	6;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	86	gadW	729	178	93.26	gadW.l15.c30.ctg.1	178	5.8	0	.	p	.	0	R102G	NONSYN	304	306	CGG	23	25	GGG	7;7;7	G;G;G	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	86	gadW	729	178	93.26	gadW.l15.c30.ctg.1	178	5.8	0	.	p	.	0	K110N	NONSYN	328	330	AAA	47	49	AAT	8;8;8	A;A;T	8;8;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	332	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1134	15.6	0	.	p	.	0	F53L	NONSYN	157	159	TTC	392	394	TTA	14;14;13	T;T;A	14;14;13	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	332	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1134	15.6	0	.	p	.	0	V79I	NONSYN	235	237	GTT	470	472	ATT	8;8;9	A;T;T	8;8;9	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	332	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1134	15.6	0	.	p	.	0	R246G	NONSYN	736	738	AGA	971	973	GGA	14;14;14	G;G;A	14;14;14	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	332	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1134	15.6	0	.	p	.	0	S248P	NONSYN	742	744	TCG	977	979	CCG	13;13;13	C;C;G	13;13;13	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1496	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3063	26.2	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2232	2234	GAA	31;31;31	G;A;A	31;31;31	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1496	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3063	26.2	1	SNP	p	S83W	0	.	.	247	249	TCG	447	449	TCG	32;32;33	T;C;G	31;32;33	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1496	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3063	26.2	1	SNP	p	S83I	0	.	.	247	249	TCG	447	449	TCG	32;32;33	T;C;G	31;32;33	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1496	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3063	26.2	1	SNP	p	S83L	0	.	.	247	249	TCG	447	449	TCG	32;32;33	T;C;G	31;32;33	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1496	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3063	26.2	1	SNP	p	D87N	0	.	.	259	261	GAC	459	461	GAC	33;33;33	G;A;C	30;33;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1496	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3063	26.2	1	SNP	p	D87H	0	.	.	259	261	GAC	459	461	GAC	33;33;33	G;A;C	30;33;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1496	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3063	26.2	1	SNP	p	D87V	0	.	.	259	261	GAC	459	461	GAC	33;33;33	G;A;C	30;33;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1496	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3063	26.2	1	SNP	p	D87Y	0	.	.	259	261	GAC	459	461	GAC	33;33;33	G;A;C	30;33;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1496	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3063	26.2	1	SNP	p	D87G	0	.	.	259	261	GAC	459	461	GAC	33;33;33	G;A;C	30;33;31	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1490	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2886	27.5	1	SNP	p	R136S	0	.	.	406	408	CGC	632	634	CGC	25;25;25	C;G;C	25;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1490	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2886	27.5	1	SNP	p	R136G	0	.	.	406	408	CGC	632	634	CGC	25;25;25	C;G;C	25;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1490	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2886	27.5	1	SNP	p	R136I	0	.	.	406	408	CGC	632	634	CGC	25;25;25	C;G;C	25;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1490	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2886	27.5	1	SNP	p	R136E	0	.	.	406	408	CGC	632	634	CGC	25;25;25	C;G;C	25;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1490	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2886	27.5	1	SNP	p	R136C	0	.	.	406	408	CGC	632	634	CGC	25;25;25	C;G;C	25;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1490	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2886	27.5	1	SNP	p	R136H	0	.	.	406	408	CGC	632	634	CGC	25;25;25	C;G;C	25;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1490	gyrB_1	2415	2415	99.13	gyrB_1.l15.c30.ctg.1	2886	27.5	1	SNP	p	R136L	0	.	.	406	408	CGC	632	634	CGC	25;25;25	C;G;C	25;25;25	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	284	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	1060	14.2	0	.	p	.	0	A72P	NONSYN	214	216	GCG	429	431	CCG	18;18;15	C;C;G	18;18;15	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	284	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	1060	14.2	0	.	p	.	0	T123A	NONSYN	367	369	ACC	582	584	GCC	28;28;28	G;C;C	28;28;28	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	558	leuO	945	945	99.26	leuO.l6.c4.ctg.1	1269	23.4	0	.	p	.	0	P9S	NONSYN	25	27	CCA	180	182	TCA	14;18;19	T;C;A	14;17;19	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	164	marA	384	384	99.74	marA.l15.c4.ctg.1	812	10.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	568	570	AGC	5;5;5	A;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	670	672	CAT	1;1;1	C;A;T	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	V45E	0	.	.	133	135	GTG	394	396	GTG	14;15;15	G;T;G	14;13;15	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	I49S	0	.	.	145	147	ATC	406	408	ATC	17;17;17	A;T;C	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	A70T	0	.	.	208	210	GCA	469	471	GCA	4;4;4	G;C;A	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	R73C	0	.	.	217	219	CGT	478	480	CGT	4;4;3	C;G;T	4;4;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	R73S	0	.	.	217	219	CGT	478	480	CGT	4;4;3	C;G;T	4;4;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	R77C	0	.	.	229	231	CGC	490	492	CGC	3;3;3	C;G;C	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	R77L	0	.	.	229	231	CGC	490	492	CGC	3;3;3	C;G;C	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	L78M	0	.	.	232	234	CTG	493	495	CTG	3;3;3	C;T;G	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	R94S	0	.	.	280	282	CGC	541	543	CGC	3;3;3	C;G;C	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	R94H	0	.	.	280	282	CGC	541	543	CGC	3;3;3	C;G;C	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	92	marR	435	416	97.6	marR.l15.c30.ctg.1	677	7.0	1	SNP	p	V96E	0	.	.	286	288	GTA	547	549	GTA	4;4;4	G;T;A	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	S7F	NONSYN	19	21	TCC	3	5	TTC	1;1;1	T;T;C	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	R36I	NONSYN	106	108	AGG	90	92	ATC	12;11;10	A;T;C	12;11;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	E42A	NONSYN	124	126	GAA	108	110	GCC	5;5;5	G;C;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	N43V	NONSYN	127	129	AAT	111	113	GTG	4;4;4	G;T;G	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	E52D	NONSYN	154	156	GAG	138	140	GAT	7;7;7	G;A;T	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	N59T	NONSYN	175	177	AAC	159	161	ACC	7;8;8	A;C;C	7;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	I68L	NONSYN	202	204	ATA	186	188	TTA	12;12;12	T;T;A	12;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	327	329	CAG	29;29;28	C;A;G	29;29;28	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	D128A	NONSYN	382	384	GAC	366	368	GCC	18;17;17	G;C;C	18;17;17	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	S163A	NONSYN	487	489	TCG	471	473	GCG	13;13;12	G;C;G	13;13;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	L231V	NONSYN	691	693	CTT	675	677	GTT	12;13;14	G;T;T	8;11;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	392	mdfA	1233	1217	96.96	mdfA.l15.c4.ctg.1	1391	14.7	0	.	p	.	0	R285fs	FSHIFT	853	853	C	837	837	C	11	C	11	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	386	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1728	12.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	264	264	G	20	G	19	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	386	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1728	12.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	321	323	CAG	5;7;8	C;A;G	5;7;8	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	386	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1728	12.0	0	.	p	.	0	T83I	NONSYN	247	249	ACC	471	473	ATC	17;17;18	A,C;T;C	16,1;17;18	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	386	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1728	12.0	0	.	p	.	0	I99M	NONSYN	295	297	ATA	519	521	ATG	7;7;8	A;T;G	7;7;8	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	386	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1728	12.0	0	.	p	.	0	A130T	NONSYN	388	390	GCC	612	614	ACC	15;15;15	A;C;C	15;15;15	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1762	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3494	27.0	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2010	2012	ACC	33;34;34	A;C;C	33;34;34	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1762	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3494	27.0	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2403	2405	CAA	20;18;17	C;A;A	18;18;15	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1762	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3494	27.0	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2571	2573	ATT	8;8;8	A;T;T	8;8;8	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1762	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3494	27.0	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2655	2657	GTT	28;27;28	G;T;T	28;27;28	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1762	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3494	27.0	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2763	2765	GAG	14;14;14	G;A;G	14;14;14	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1762	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3494	27.0	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2991	2993	ATG	23;24;23	A;T;G	23;24;23	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1762	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3494	27.0	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3126	3128	GAT	25;24;24	G;A;T	25;23;24	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1498	mdtC	3078	3078	98.67	mdtC.l15.c17.ctg.1	3268	24.1	0	.	p	.	0	I21L	NONSYN	61	63	ATT	176	178	CTT	5;6;6	C,A;T;T	0,4;6;6	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1498	mdtC	3078	3078	98.67	mdtC.l15.c17.ctg.1	3268	24.1	0	.	p	.	0	I46M	NONSYN	136	138	ATC	251	253	ATG	12;12;12	A;T;G	12;12;12	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1498	mdtC	3078	3078	98.67	mdtC.l15.c17.ctg.1	3268	24.1	0	.	p	.	0	V208I	NONSYN	622	624	GTC	737	739	ATC	28;29;27	A;T;C	28;29;27	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1498	mdtC	3078	3078	98.67	mdtC.l15.c17.ctg.1	3268	24.1	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3053	3055	CAC	3;3;3	C;A;C	3;3;3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	656	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1884	18.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	212	214	GAA	13;13;12	G;A;A	13;13;12	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	656	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1884	18.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	881	883	GCG	23;23;23	G;C;G	23;23;23	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	656	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1884	18.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1223	1225	ATC	28;28;28	A;T;C	27;28;28	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	656	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1884	18.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1526	1528	TTT	21;20;20	T;T;T	21;20;20	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	774	mdtE	1158	1158	99.31	mdtE.l15.c17.ctg.1	1686	24.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1990	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3626	29.5	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1130	1132	ACC	20;21;23	A;C;C	20;20;23	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1990	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3626	29.5	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2372	2374	GAC	36;37;38	G;A;C	35;36;37	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	550	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1503	15.9	0	.	p	.	0	V200I	NONSYN	598	600	GTC	645	647	ATC	14;14;14	A;T;C	14;14;14	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	550	mdtG	1227	168	100.0	mdtG.l15.c4.ctg.4	177	14.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	454	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1435	16.5	0	.	p	.	0	G134C	NONSYN	400	402	GGT	604	606	TGT	32;32;32	T;G;T	31;32;32	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	454	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1435	16.5	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1174	1176	TTG	16;15;13	T;T;G	16;15;13	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	454	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1435	16.5	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1279	1281	CAG	8;8;7	C;A;G	8;8;7	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	454	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1435	16.5	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1384	1386	ACG	5;5;5	A;C;G	5;5;5	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	702	mdtL	1176	1176	98.47	mdtL.l15.c30.ctg.1	1760	21.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	842	844	TCC	21;21;20	T;C;C	19;21;20	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	168	mdtN	1032	1032	98.16	mdtN.l6.c4.ctg.1	1174	7.0	0	.	p	.	0	V119I	NONSYN	355	357	GTT	466	468	ATT	6;6;6	A;T;T	6;6;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	V11M	NONSYN	31	33	GTG	171	173	ATG	5;5;5	A;T;G	5;5;5	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	T33I	NONSYN	97	99	ACC	237	239	ATC	9;9;9	A;T;C	9;9;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	C116R	NONSYN	346	348	TGC	486	488	CGC	11;12;11	C;G;C	11;12;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	N238S	NONSYN	712	714	AAC	852	854	AGC	13;13;13	A;G;C	13;12;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1053	1055	GTG	12;12;12	G;T;G	12;11;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1116	1118	AAC	3;3;3	A;A,C;C	3;2,1;3	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1161	1163	GTC	10;9;9	G;T;C	10;9;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1191	1193	ATA	7;7;7	A;T;A	7;7;7	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1299	1301	TCT	7;9;9	T;C;T	7;9;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1686	1688	GCG	9;9;9	G;C;G	9;9;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	388	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2367	8.7	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1899	1901	ATC	10;10;10	A;T;C	10;10;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	214	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1554	7.0	0	.	p	.	0	S129A	NONSYN	385	387	TCA	400	402	GCG	6;6;8	G;C;G	6;6;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	214	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1554	7.0	0	.	p	.	0	A187T	NONSYN	559	561	GCC	574	576	ACC	4;4;4	A;C;C	4;4;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	214	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1554	7.0	0	.	p	.	0	H211R	NONSYN	631	633	CAC	646	648	CGC	6;7;7	C;G;C	6;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	214	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1554	7.0	0	.	p	.	0	V250A	NONSYN	748	750	GTT	763	765	GCT	6;6;6	G;C;T	6;6;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	214	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1554	7.0	0	.	p	.	0	R278K	NONSYN	832	834	AGA	847	849	AAA	4;3;3	A;A;A	4;3;3	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	214	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1554	7.0	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	865	867	CGA	5;5;5	C;G;A	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	214	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1554	7.0	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1030	1032	GCC	5;5;5	G;C;C	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	214	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1554	7.0	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1042	1044	GAT	6;6;6	G;A;T	6;6;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	214	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1554	7.0	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1459	1461	GCT	2;2;2	G;C;T	2;2;2	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1556	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3829	21.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1501	1503	AAG	16;15;14	A;A;G	16;15;14	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1556	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3829	21.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2578	2580	CTG	19;20;21	C;T;G	19;19;21	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	118	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	164	19.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1030	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2224	25.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1006	1008	AAC	15;17;17	A;A;C	15;16;17	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1030	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2224	25.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1552	1554	ATA	21;20;21	A;T;A	21;20;20	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	786	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1687	24.7	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1203	1205	GTG	26;28;27	G;T;G	25;28;27	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	786	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1687	24.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1281	1283	GAT	31;29;28	G;A;T	31;29;28	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	786	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1687	24.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1284	1286	CTG	29;29;31	C;T;G	29;29;31	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	312	nfsA	723	723	98.89	nfsA.l6.c4.ctg.1	1167	14.2	1	SNP	p	R15C	1	R15C	NONSYN	43	45	CGC	213	215	TGC	16;14;14	T;G;C	16;14;14	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	312	nfsA	723	723	98.89	nfsA.l6.c4.ctg.1	1167	14.2	0	.	p	.	0	R27C	NONSYN	79	81	CGT	249	251	TGT	11;13;14	T;G;T	11;13;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	312	nfsA	723	723	98.89	nfsA.l6.c4.ctg.1	1167	14.2	0	.	p	.	0	I117T	NONSYN	349	351	ATC	519	521	ACC	14;15;15	A;C;C	14;15;15	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	312	nfsA	723	723	98.89	nfsA.l6.c4.ctg.1	1167	14.2	0	.	p	.	0	G187D	NONSYN	559	561	GGC	729	731	GAC	18;18;17	G;A;C	18;18;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	312	nfsA	723	723	98.89	nfsA.l6.c4.ctg.1	1167	14.2	1	SNP	p	S33R	0	.	.	97	99	AGC	267	269	AGC	16;16;16	A;G;C	16;16;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	312	nfsA	723	723	98.89	nfsA.l6.c4.ctg.1	1167	14.2	1	SNP	p	G131D	0	.	.	391	393	GGC	561	563	GGC	25;25;25	G;G;C	25;24;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	312	nfsA	723	723	98.89	nfsA.l6.c4.ctg.1	1167	14.2	1	SNP	p	R203L	0	.	.	607	609	CGT	777	779	CGT	16;15;16	C;G;T	16;15;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	312	nfsA	723	723	98.89	nfsA.l6.c4.ctg.1	1167	14.2	1	SNP	p	R203C	0	.	.	607	609	CGT	777	779	CGT	16;15;16	C;G;T	16;15;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	686	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1470	24.7	1	SNP	p	G141D	0	.	.	421	423	GGT	604	606	GGT	38;38;38	G;G;T	38;38;38	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	686	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1470	24.7	1	SNP	p	G141E	0	.	.	421	423	GGT	604	606	GGT	38;38;38	G;G;T	38;38;38	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	686	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1470	24.7	1	SNP	p	R154A	0	.	.	460	462	CGT	643	645	CGT	43;44;43	C;G;T	43;44;42	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	686	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1470	24.7	1	SNP	p	R154D	0	.	.	460	462	CGT	643	645	CGT	43;44;43	C;G;T	43;44;42	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1352	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2718	26.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1900	1902	TCG	39;39;39	T;C;G	36;39;39	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1352	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2718	26.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2515	2517	AAC	30;30;30	A;A;C	30;30;30	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1352	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2718	26.6	1	SNP	p	A85T	0	.	.	253	255	GCG	529	531	GCG	31;30;30	G;C;G	30;30;29	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1352	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2718	26.6	1	SNP	p	D111H	0	.	.	331	333	GAT	607	609	GAT	23;24;24	G;A;T	23;23;24	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1352	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2718	26.6	1	SNP	p	S129P	0	.	.	385	387	TCC	661	663	TCC	22;22;22	T;C;C	22;22;22	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	952	parE_1	1893	1746	97.48	parE_1.l15.c4.ctg.1	2030	22.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1279	1281	GAT	42;41;42	G;A;T	42;40;42	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	952	parE_1	1893	128	99.22	parE_1.l15.c4.ctg.2	421	11.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	850	patA	1380	1380	99.86	patA.l15.c30.ctg.1	1889	24.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1333	1335	GAT	25;24;23	G;A;T	25;24;23	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	V146F	0	.	.	436	438	GTT	746	748	GTT	34;33;34	G;T;T	34;33;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1847	1849	CAG	40;40;40	C;A;G	40;40;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1847	1849	CAG	40;40;40	C;A;G	40;40;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1886	1888	CAC	36;36;36	C;A;C	36;36;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1895	1897	CGT	36;36;35	C;G;T	36;36;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1895	1897	CGT	36;36;35	C;G;T	36;36;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1901	1903	TCC	32;32;32	T;C;C	32;31;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1907	1909	CTC	31;31;30	C;T;C	31;31;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1997	1999	ACC	42;41;42	A;C;C	42;41;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	2000	2002	CCT	42;41;42	C;C;T	42;41;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2944	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4632	34.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2369	2371	CGT	65;64;60	C;G;T	65;64;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	.	n	.	0	A226G	SNP	226	226	A	381	381	G	236	G,A	234,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	1	SNP	n	A794G	0	.	.	794	794	A	949	949	A	228	A,C	223,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	1	SNP	n	A794T	0	.	.	794	794	A	949	949	A	228	A,C	223,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	1	SNP	n	G926A	0	.	.	926	926	G	1081	1081	G	227	G	225	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	1	SNP	n	G926T	0	.	.	926	926	G	1081	1081	G	227	G	225	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	1	SNP	n	G926C	0	.	.	926	926	G	1081	1081	G	227	G	225	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	1	SNP	n	A1519T	0	.	.	1519	1519	A	1674	1674	A	123	A	123	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	1	SNP	n	A1519C	0	.	.	1519	1519	A	1674	1674	A	123	A	123	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	1	SNP	n	A1519G	0	.	.	1519	1519	A	1674	1674	A	123	A	123	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	G1002A	.	1002	1002	G	1157	1157	G	229	G,A	171,58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	G1006C	.	1006	1006	G	1161	1161	G	224	G,C	168,54	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	A79G	.	79	79	A	234	234	A	196	A,G	140,54	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	C719T	.	719	719	C	874	874	C	203	C,T	125,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	T273A	.	273	273	T	428	428	T	232	T,A	166,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	T1010C	.	1010	1010	T	1165	1165	T	224	T,C	166,55	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	C1038T	.	1038	1038	C	1193	1193	C	217	C,T	159,58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	C183T	.	183	183	C	338	338	C	185	C,T	137,45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	T90C	.	90	90	T	245	245	T	199	T,C	141,56	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	A250T	.	250	250	A	405	405	A	218	A,T	155,61	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	G474A	.	474	474	G	629	629	G	233	G,A	188,45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	A253T	.	253	253	A	408	408	A	216	A,T	154,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	7232	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1710	211.8	0	HET	.	.	.	C194T	.	194	194	C	349	349	C	197	C,T	167,30	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	258	soxR	465	465	100.0	soxR.l15.c30.ctg.1	793	17.3	1	SNP	p	R20H	0	.	.	58	60	CGC	200	202	CGC	25;26;25	C;G;C	24;25;25	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	258	soxR	465	465	100.0	soxR.l15.c30.ctg.1	793	17.3	1	SNP	p	G121D	0	.	.	361	363	GGT	503	505	GGT	24;26;27	G;G;T	23;26;26	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	238	soxS_1	324	324	99.69	soxS_1.l6.c30.ctg.1	828	15.5	1	SNP	p	A12S	0	.	.	34	36	GCA	278	280	GCA	28;28;27	G;C;A	28;28;27	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	934	tolC	1488	1488	98.72	tolC.l6.c4.ctg.1	1975	25.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
